Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly E Dunn

Showing results (61-70 of 165) with videos related to

Pageof 17
Sort By:
Drug and Alcohol Dependence|February 28, 2021
Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorderSandeep M Nayak, Andrew S Huhn, Cecilia L Bergeria, et al.
Journal of Addiction Medicine|November 24, 2021
Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use FentanylNeil B Varshneya, Ashish P Thakrar, J Gregory Hobelmann, et al.
Journal of Applied Behavior Analysis|February 6, 2009
Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot studyKelly E Dunn, Stacey C Sigmon, Colleen S Thomas, et al.
Journal of Substance Abuse Treatment|February 26, 2008
Evaluation of ongoing oxycodone abuse among methadone-maintained patientsKelly E Dunn, Stacey C Sigmon, Mark R McGee, et al.
Drug and Alcohol Dependence|April 1, 2015
Characterizing opioid withdrawal during double-blind buprenorphine detoxificationKelly E Dunn, Kathryn A Saulsgiver, Mollie E Miller, et al.
Journal of Dual Diagnosis|October 5, 2023
Factors Associated with High-Risk Substance Use in Persons Receiving Psychiatric Treatment for a Primary Trauma- and Stressor-Related Disorder DiagnosisOrrin D Ware, Justin C Strickland, Kirsten E Smith, et al.
Journal of Addiction Medicine|November 6, 2020
Provider Continuity in the Prescribing of Buprenorphine/Naloxone Within Medicare Part DJustin C Strickland, Andrew S Huhn, Cecilia L Bergeria, et al.
Journal of Psychopharmacology (Oxford, England)|April 9, 2020
Evaluating the co-use of opioids and cannabis for pain among current users using hypothetical purchase tasksCecilia L Bergeria, Sean B Dolan, Matthew W Johnson, et al.
Drug and Alcohol Dependence|July 12, 2011
The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a reviewKelly E Dunn, Stacey C Sigmon, Eric C Strain, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 18, 2015
Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking CessationKelly E Dunn, Taylor F Marcus, Cynthia Kim, et al.
Pageof 17

Showing results (61-70 of 165) with videos related to

Sort By:
Pageof 17
Drug and Alcohol Dependence|February 28, 2021
Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorderSandeep M Nayak, Andrew S Huhn, Cecilia L Bergeria, et al.
Journal of Addiction Medicine|November 24, 2021
Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use FentanylNeil B Varshneya, Ashish P Thakrar, J Gregory Hobelmann, et al.
Journal of Applied Behavior Analysis|February 6, 2009
Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot studyKelly E Dunn, Stacey C Sigmon, Colleen S Thomas, et al.
Journal of Substance Abuse Treatment|February 26, 2008
Evaluation of ongoing oxycodone abuse among methadone-maintained patientsKelly E Dunn, Stacey C Sigmon, Mark R McGee, et al.
Drug and Alcohol Dependence|April 1, 2015
Characterizing opioid withdrawal during double-blind buprenorphine detoxificationKelly E Dunn, Kathryn A Saulsgiver, Mollie E Miller, et al.
Journal of Dual Diagnosis|October 5, 2023
Factors Associated with High-Risk Substance Use in Persons Receiving Psychiatric Treatment for a Primary Trauma- and Stressor-Related Disorder DiagnosisOrrin D Ware, Justin C Strickland, Kirsten E Smith, et al.
Journal of Addiction Medicine|November 6, 2020
Provider Continuity in the Prescribing of Buprenorphine/Naloxone Within Medicare Part DJustin C Strickland, Andrew S Huhn, Cecilia L Bergeria, et al.
Journal of Psychopharmacology (Oxford, England)|April 9, 2020
Evaluating the co-use of opioids and cannabis for pain among current users using hypothetical purchase tasksCecilia L Bergeria, Sean B Dolan, Matthew W Johnson, et al.
Drug and Alcohol Dependence|July 12, 2011
The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a reviewKelly E Dunn, Stacey C Sigmon, Eric C Strain, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 18, 2015
Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking CessationKelly E Dunn, Taylor F Marcus, Cynthia Kim, et al.
Pageof 17